Candida albicans Filamentation Does Not Require the cAMP-PKA Pathway In Vivo

The fungus Candida albicans causes a wide range of disease in humans from common diaper rash to life-threatening infections in patients with compromised immune systems. As such, the mechanisms for its ability to cause disease are of wide interest. ABSTRACT Candida albicans is one of the most prevalent human fungal pathogens. Its ability to transition between budding yeast and filamentous morphological forms (pseudohyphae and hyphae) is tightly associated with its pathogenesis. Based on in vitro studies, the cAMP-protein kinase A (PKA) pathway is a key regulator of C. albicans morphogenesis. Using an intravital imaging approach, we investigated the role of the cAMP-PKA pathway during infection. Consistent with their roles in vitro, the downstream effectors of the cAMP-PKA pathway Efg1 and Nrg1 function, respectively, as an activator and a repressor of in vivo filamentation. Surprisingly, strains lacking the adenylyl cyclase, CYR1, showed only slightly reduced filamentation in vivo despite being completely unable to filament in RPMI + 10% serum at 37°C. Consistent with these findings, deletion of the catalytic subunits of PKA (Tpk1 and Tpk2), either singly or in combination, generated strains that also filamented in vivo but not in vitro. In vivo transcription profiling of C. albicans isolated from both ear and kidney tissue showed that the expression of a set of 184 environmentally responsive genes correlated well with in vitro filamentation (R2, 0.62 to 0.68) genes. This concordance suggests that the in vivo and in vitro transcriptional responses are similar but that the upstream regulatory mechanisms are distinct. As such, these data emphatically emphasize that C. albicans filamentation is a complex phenotype that occurs in different environments through an intricate network of distinct regulatory mechanisms. IMPORTANCE The fungus Candida albicans causes a wide range of disease in humans from common diaper rash to life-threatening infections in patients with compromised immune systems. As such, the mechanisms for its ability to cause disease are of wide interest. An intensely studied virulence property of C. albicans is its ability to switch from a round yeast form to filament-like forms (hyphae and pseudohyphae). Surprisingly, we have found that a key signaling pathway that regulates this transition in vitro, the protein kinase A pathway, is not required for filamentation during infection of the host. Our work not only demonstrates that the regulation of filamentation depends upon the specific environment C. albicans inhabits but also underscores the importance of studying these mechanisms during infection.

[1]  A. Mitchell,et al.  Systematic Genetic Interaction Analysis Identifies a Transcription Factor Circuit Required for Oropharyngeal Candidiasis , 2022, mBio.

[2]  M. Lionakis,et al.  Pathogenesis and virulence of Candida albicans , 2021, Virulence.

[3]  K. Veeramah,et al.  Integrative multi-omics profiling reveals cAMP-independent mechanisms regulating hyphal morphogenesis in Candida albicans , 2021, bioRxiv.

[4]  A. Mitchell,et al.  Intravital Imaging of Candida albicans Identifies Differential In Vitro and In Vivo Filamentation Phenotypes for Transcription Factor Deletion Mutants , 2021, bioRxiv.

[5]  T. Hazbun,et al.  Transcriptional control of hyphal morphogenesis in Candida albicans , 2020, FEMS yeast research.

[6]  Guanghua Huang,et al.  Multiple roles and diverse regulation of the Ras/cAMP/protein kinase A pathway in Candida albicans , 2018, Molecular microbiology.

[7]  Guanghua Huang,et al.  Global regulatory roles of the cAMP/PKA pathway revealed by phenotypic, transcriptomic and phosphoproteomic analyses in a null mutant of the PKA catalytic subunit in Candida albicans , 2017, Molecular microbiology.

[8]  A. Mitchell,et al.  Marker Recycling in Candida albicans through CRISPR-Cas9-Induced Marker Excision , 2017, mSphere.

[9]  J. Konopka,et al.  cAMP‐independent signal pathways stimulate hyphal morphogenesis in Candida albicans , 2017, Molecular microbiology.

[10]  A. Mitchell,et al.  Activation and Alliance of Regulatory Pathways in C. albicans during Mammalian Infection , 2015, PLoS biology.

[11]  B. Kullberg,et al.  Invasive Candidiasis. , 2015, The New England journal of medicine.

[12]  Haopin Liu,et al.  Candida albicans hyphal initiation and elongation. , 2014, Trends in microbiology.

[13]  Judith Berman.  Candida albicans , 2012, Current Biology.

[14]  P. Sudbery.  Growth of Candida albicans hyphae , 2011, Nature Reviews Microbiology.

[15]  T. Foster,et al.  Imaging morphogenesis of Candida albicans during infection in a live animal. , 2010, Journal of biomedical optics.

[16]  Alexander D. Johnson,et al.  A Phenotypic Profile of the Candida albicans Regulatory Network , 2009, PLoS genetics.

[17]  J. Lopez-Ribot,et al.  Engineered Control of Cell Morphology In Vivo Reveals Distinct Roles for Yeast and Filamentous Forms of Candida albicans during Infection , 2003, Eukaryotic Cell.

[18]  A. Brown,et al.  NRG1 represses yeast–hypha morphogenesis and hypha‐specific gene expression in Candida albicans , 2001, The EMBO journal.

[19]  B. R. Braun,et al.  NRG1, a repressor of filamentous growth in C.albicans, is down‐regulated during filament induction , 2001, The EMBO journal.

[20]  J. Ernst,et al.  A potential phosphorylation site for an A-type kinase in the Efg1 regulator protein contributes to hyphal morphogenesis of Candida albicans. , 2001, Genetics.

[21]  S. Tzipori,et al.  Invasive Lesions Containing Filamentous Forms Produced by a Candida albicans Mutant That Is Defective in Filamentous Growth in Culture , 1999, Infection and Immunity.